CVE-2022-2143
The affected product is vulnerable to two instances of command injection, which may allow an attacker to remotely execute arbitrary code.
Does this matter?
EPSS puts the probability of exploitation in the next 30 days at 62.6%, higher than 99% of all known CVEs. Patch or mitigate before the next change window.
Description
The affected product is vulnerable to two instances of command injection, which may allow an attacker to remotely execute arbitrary code.
- CVSS 3.1
- 9.8 CRITICALCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 62.62% probability · 99th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Weakness
- CWE-77
- Affected
- advantech/iview
- Source
- ics-cert@hq.dhs.gov
EPSS moved from 62.6% on 25 October 2026 to 62.6% on 3 November 2026. The dashed line is the ten per cent mark our analysts treat as “patch before the next change window”.
References
- http://packetstormsecurity.com/files/168108/Advantech-iView-NetworkServlet-Command-Injection.htmlExploit, Third Party Advisory, VDB Entry
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-179-03Third Party Advisory, US Government Resource
- http://packetstormsecurity.com/files/168108/Advantech-iView-NetworkServlet-Command-Injection.htmlExploit, Third Party Advisory, VDB Entry
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-179-03Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.